Answers are grounded in this paper and cite their sources.
To provide matched blood for transfusion. Target genes: Red blood cell (RBC) antigen.Testing process: Testing performed IN-HOUSE.In-house commercial assays: Sequence-specific PCR with agarose gel electrophoresis (e.g., Inno-train, BAGgene). Sequence-specific PCR with real-time fluorescence detection (e.g., Inno-train RBC-FluoGene, OneLambda for HLA testing).In-house laboratory-developed assays: PCR or RFLP.Masking of non-blood-group-related genes after completing WGS: Not applicable, we do NOT perform next-generation sequencing, whole-genome sequencing (WGS) IN-HOUSE.Are donors informed that their blood (may/will) undergo molecular/ genetic testing?Yes.If so, how?General consent form (i.e., consent for genetic testing is implicitly or explicitly included in the general consent form for blood donors).
No takes yet. Share an insight, caveat, or question.
Haw et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: